Legal Representation
Attorney
Michael E. Hall
USPTO Deadlines
Application History
24 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
May 9, 2016 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
May 9, 2016 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Mar 16, 2016 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
Oct 13, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 10, 2015 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Oct 10, 2015 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Oct 6, 2015 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Oct 6, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 6, 2015 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Apr 7, 2015 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Feb 10, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Feb 10, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jan 21, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jan 6, 2015 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Jan 2, 2015 | ALIE | A | ASSIGNED TO LIE | Loading... |
Dec 15, 2014 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Dec 12, 2014 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Dec 12, 2014 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Dec 12, 2014 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Dec 12, 2014 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Dec 5, 2014 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 4, 2014 | MPMK | E | NOTICE OF PSEUDO MARK E-MAILED | Loading... |
Sep 3, 2014 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Aug 23, 2014 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; pharmaceutical preparations for wounds; veterinary pharmaceutical compounds for equine use to treat conditions of the leg, hoof, ear, nose and throat
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
BIO STREAM
Classification
International Classes
005